fbpx
May 24, 2021

Obesity Hope as Neuropeptide Y Blocker Turns White Fat to Brown Obesity Hope as Neuropeptide Y Blocker Turns White Fat to Brown

A peripherally acting substance that boosts energy expenditure and reduces fat mass has the potential to become an obesity treatment that doesn’t produce cardiovascular or psychiatric […]
May 24, 2021

Physicians’ Trust in Healthcare Leadership Drops in Pandemic Physicians’ Trust in Healthcare Leadership Drops in Pandemic

Physicians’ trust in healthcare system leaders has taken a steep drop during the COVID-19 pandemic, according to a survey conducted by NORC at the University of […]
May 23, 2021

Surprising Percentage of Biopsy Samples Retained in GI Endoscopes Surprising Percentage of Biopsy Samples Retained in GI Endoscopes

Researchers examining GI endoscopes after colonoscopy and esophagogastroduodenoscopy (EGD) procedures found a “startingly high” rate of retained biopsy samples in the endoscope accessory channel or cap. […]
May 22, 2021

Prague OHCA: Hyperinvasive Care, Better Cardiac Arrest Outcomes? Prague OHCA: Hyperinvasive Care, Better Cardiac Arrest Outcomes?

Patients with refractory out-of-hospital cardiac arrest (OHCA) receiving “hyperinvasive” rather than standard care had better overall outcomes, researchers in the randomized Prague OHCA trial conclude. The […]
May 22, 2021

‘Smart Toilet’ With AI Scans Stool for Blood, Consistency ‘Smart Toilet’ With AI Scans Stool for Blood, Consistency

A ‘smart toilet’ in development uses artificial intelligence (AI) to scan stool for consistency and presence of blood — and early evidence suggests it is more […]
May 21, 2021

Healthy Lifestyle Tied to Reduced Dementia Despite Family History Healthy Lifestyle Tied to Reduced Dementia Despite Family History

Individuals at increased risk for dementia because of family history can reduce that risk by adopting healthy lifestyle behaviors, data from more than 300,000 adults aged […]
May 21, 2021

VENUS: Ustekinumab Superior to Vedolizumab for Refractory Crohn’s VENUS: Ustekinumab Superior to Vedolizumab for Refractory Crohn’s

In a first direct comparison study, ustekinumab (Stelara, Janssen) emerged superior to vedolizumab (Entyvio, Takeda) on multiple measures of response and remission among patients with Crohn’s […]
May 21, 2021

VENUS: Ustekinumab Appears Superior to Vedolizumab for Crohn’s VENUS: Ustekinumab Appears Superior to Vedolizumab for Crohn’s

Updated May 22, 2021 // Editor’s note: This story has been updated with comments from Dr Farah Monzur of Stony Brook Medicine. Ustekinumab (Stelara, Janssen) appears superior […]
May 21, 2021

White House, Dating Apps Unite to Push Vaccination White House, Dating Apps Unite to Push Vaccination

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. May 21, 2021 — People looking for love on dating apps can now find matches based […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482483484485486487488489490491492493494495496497498499500501502503504505506507508509510511512513514515516517518519520521522523524525526527528529530531532533534535536537538539540541542543544545546547548549550551552553554555556557558559560561562563564565566567568569570571572573574575576577578579580581582583584585586587588589590591592593594595596597598599600601602603604605606607608609610611612613614615616617618619620621622623624625626627628629630631632633634635636637638639640641642643644645646647648649650651652653654655656657658659660661662663664665666667668669670671672673674675676677678679680681682683684685686687688689690691692693694695696697698699700701702703704705706707708709710711712713714715716717718719720721722723724725726727728729730731732733734735736737738739740741742743744745746747748749750751752753754755756757758759760761762763764765766767768769770771772773774775776777778779780781782783784785786787788789790791792793794795796797798799800801802803804805806807808809810811812813814815816817818819820821822823824825826827828829830831832833834835836837838839840841842843844845846847848849850851852853854855856857858859860861862863864865866867868869870871872873874875876877878879880881882883884885886887888889890891892893894895896897898899900901902903904905906907908909910911912913914915916917918919920921922923924925926927928929930931932933934935936937938939940941942943944945946947948949950951952953954955956957958959960961962963964965966967968969970971972973974975976977978979980981982983984985986987988989990991992993994995996997998999100010011002100310041005100610071008100910101011101210131014101510161017101810191020102110221023102410251026102710281029103010311032103310341035103610371038103910401041104210431044104510461047104810491050105110521053105410551056105710581059106010611062106310641065
Next page
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0